Home/Pipeline/Undisclosed Regenerative Medicine Program(s)

Undisclosed Regenerative Medicine Program(s)

Regenerative Medicine

Pre-clinicalActive

Key Facts

Indication

Regenerative Medicine

Phase

Pre-clinical

Status

Active

Company

Cell BioEngines

About Cell BioEngines

Cell BioEngines is an emerging player in the allogeneic cell therapy space, leveraging a proprietary 'super-donor' stem cell platform to create transgene-free, scalable therapies. Its strategy combines HLA-guided design with a population-informed biobank to achieve broad patient coverage across multiple diseases. The company operates with a therapeutic area-agnostic, portfolio-focused business model aimed at reducing development time, translational costs, and overall risk.

View full company profile

Therapeutic Areas

Oncology Regenerative Medicine

Other Regenerative Medicine Drugs

Drug	Company	Phase	Status
Rational Protocol Design for Cell Therapy	Cellular Intelligence	Research/Pre-clinical	Active
Pluristyx Partnership (iPSC-MSC Banks)	Stemmatters	Development	Active
Accelerated Biosciences Collaboration (Trophoblast iPSC)	Stemmatters	Development	Active
Undisclosed Program	CRISPR Therapeutics	Preclinical	Preclinical